ESP brings real-time enhanced decision making to the OR with unmatched precision, offering a game changing advantage. Join us in advancing the future of minimally invasive surgery.
ESP in action: Real-time anomaly detection with visual overlay guidance
Our Story
From ancient healing to artificial intelligence, each breakthrough has brought us closer to perfect surgical precision.
ESP — Enhanced Surgical Precision meets Extra Sensory Perception — giving surgeons superhuman awareness in the operating room.
Egyptian texts like the Edwin Smith Papyrus describe wound treatments and tumor cauterization, establishing surgery as a healing art.
The invention of the microscope revealed the invisible world, forever changing how surgeons understand anatomy and disease.
Surgery transforms from emergency intervention to deliberate precision as anesthesia allows surgeons time to work carefully.
Laparoscopic techniques reduce trauma and recovery time, but limit surgeons' direct vision and tactile feedback.
Robotic systems enhance precision and control, yet still rely entirely on human visual interpretation and decision-making.
Artificial intelligence begins assisting with surgical planning and navigation, setting the stage for real-time guidance.
Emet Surgical's ESP system brings years of surgical intuition into every procedure, providing real-time anomaly detection that makes the invisible visible during minimally invasive surgery.
Exhibited in the Israel Innovation Authority Startup Pavilion, demonstrating ESP in real-time for the first time to international healthcare leaders. Selected as a finalist in the prestigious pitch competition, validating ESP's potential to transform surgical care.
Key Capabilities
ESP seamlessly integrates with existing surgical systems, offering strategic partners a software-only solution that enhances their platforms without hardware changes.
Advanced AI algorithms trained on extensive surgical datasets deliver exceptional anomaly detection rates, reducing the risk of missed pathology.
Near-instantaneous processing ensures surgeons receive critical information in real-time, enabling immediate response to detected anomalies.
Software-only integration with existing surgical equipment. No new hardware, no additional training, just enhanced surgical precision.
ESP works intuitively with your existing skills and workflow. Surgeons can start benefiting immediately without learning new techniques or interfaces.
Unlike other systems, ESP requires no contrast agents or fluorescent dyes, eliminating patient exposure to additional substances and associated risks.
ESP integrates seamlessly with your current laparoscopic or robotic systems. Pure software solution means no capital expenditure, no OR reconfiguration, and no need for surgeons to wear VR-style goggles.
Clinical Applications
ESP's anomaly detection capabilities target high-impact conditions where visual identification can dramatically improve patient outcomes.
Our foundational application addresses a critical gap: cancerous tissue discovered unexpectedly during routine procedures. ESP's real-time detection helps surgeons identify suspicious tissue that might otherwise go unnoticed until pathology review, potentially preventing the need for repeat surgeries.
Endometriosis affects 1 in 10 women yet often takes 7-10 years to diagnose. ESP's pattern recognition capabilities can help identify subtle endometrial lesions that are easily missed, especially in atypical presentations, enabling more complete excision during laparoscopy.
These applications demonstrate ESP's core capability: making pathology visible in real-time. As we validate these use cases, the platform will expand to address additional surgical challenges.
The Technology
Built on licensed IP from the University of Minnesota representing 20+ person-years of cutting-edge research in computer vision and AI, ESP brings institutional knowledge directly into the operating room.
We're pursuing FDA 510(k) clearance as a Class II Software as Medical Device (SaMD), with opportunities for strategic partners to shape our regulatory pathway and global market expansion into the UK, Canada, Israel (AMAR), Australia, Singapore, and other Commonwealth markets.
Clinical Validation
Studies starting soon at leading medical centers in Israel
Seeking clinical study sites in the United States
Our Mission
We're building partnerships across the healthcare ecosystem
Lead the validation of next-generation surgical AI through clinical trials at your institution.
Explore Clinical Trials →Collaborate with us to integrate ESP technology into existing surgical platforms and workflows.
Discuss Partnership →Help shape the future of surgery. We're seeking exceptional talent and advisors.
View Opportunities →For investment inquiries from accredited investors, please contact investors@emetsurgical.com